Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Allakos Inc (NQ: ALLK )

2.170 +0.040 (+1.88%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,374,319
Open 2.140
Bid (Size) 2.170 (5)
Ask (Size) 2.480 (1)
Prev. Close 2.130
Today's Range 2.020 - 2.180
52wk Range 2.020 - 8.730
Shares Outstanding 86,560,315
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Matrix Service Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Gainers AgileThought, Inc. (NASDAQ: AGIL) shares rose 72.5% to $0.2160 in pre-market trading after declining 12% on Monday. 
Via Benzinga
Allakos Appoints Neil Graham to its Board of Directors
From Allakos Inc.
Via GlobeNewswire

Performance

YTD
-73.76%
-73.76%
1 Month
-26.94%
-26.94%
3 Month
-48.82%
-48.82%
6 Month
-52.93%
-52.93%
1 Year
-59.06%
-59.06%

More News

Read More
Top 5 Health Care Stocks That Could Blast Off This Month
Via Benzinga
Allakos Provides Business Update and Reports Second Quarter 2023 Financial Results
From Allakos Inc.
Via GlobeNewswire
Analyst Ratings for Allakos
Via Benzinga
Allakos: Q1 Earnings Insights
Via Benzinga
Why Allakos Stock Was Heating Up Today
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Allakos Appoints Rand Sutherland and Dolca Thomas to its Board of Directors
From Allakos Inc.
Via GlobeNewswire
Allakos Presents Preclinical Data at EAACI Hybrid Congress 2023 Highlighting Lirentelimab and AK006 Mechanisms of Mast Cell Inhibition
From Allakos Inc.
Via GlobeNewswire
Allakos Announces Upcoming Presentation on Lirentelimab and AK006 Mast Cell Inhibition at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2023
From Allakos Inc.
Via GlobeNewswire
Where Allakos Stands With Analysts
Via Benzinga
Why Allakos Stock Skyrocketed Nearly 9% Higher Today
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023
Via Benzinga
Allakos Provides Business Update and Reports First Quarter 2023 Financial Results
From Allakos Inc.
Via GlobeNewswire
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
Via Benzinga
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
From Allakos Inc.
Via GlobeNewswire
Allakos Announces Publication of AK006 Mechanism of Action Manuscript in Communications Biology
From Allakos Inc.
Via GlobeNewswire
Allakos Presents Preclinical Data on AK007, a Siglec-10 Antagonist Antibody, at the Society for Immunotherapy of Cancer’s 37th Annual Meeting
From Allakos Inc.
Via GlobeNewswire
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Via Benzinga
DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.